24-27 November 2026Crocus Expo, Pavilion 2, Moscow
RU
Plant-based supplements market growth is moving from consumer trend to manufacturing priority across Russia, the CIS and wider Eurasia.
Plant-based supplements market growth is moving from consumer trend to manufacturing priority across Russia, the CIS and wider Eurasia. Rising demand for natural health products, preventive nutrition and plant-derived ingredients is reshaping how pharmaceutical and nutraceutical companies plan sourcing, production, packaging and distribution.
For senior production, R&D, quality, procurement and CDMO teams, the opportunity is commercially attractive but operationally demanding. Growth depends on more than access to botanical ingredients. It requires qualified suppliers, stable formulations, documented processes, compliant packaging and traceability systems that can support regulated regional expansion.
Demand is being driven by a stronger consumer focus on prevention, immunity, digestive health, mobility, sleep and healthy ageing. The World Health Organization projects that the global population aged 60 and above will reach 1.4 billion by 2030, strengthening the commercial case for supplements positioned around long-term wellbeing and daily health management.
Emerging pharmaceutical markets are also seeing greater demand for herbal supplements as middle-class consumers look for recognisable plant-based products with credible quality signals. For manufacturers, this moves plant-based supplements market growth into R&D and portfolio planning. Plant-based active ingredients need to be selected for market appeal, stability, compatibility, documentation and repeatable performance at scale.
Botanical ingredients create procurement risk because quality is shaped before the material reaches the production site. Species authentication, growing region, harvest conditions, drying method, extraction process and contamination control all influence finished-product quality. A low-cost supplier may appear competitive on price while increasing risk due to a weak batch history or incomplete technical documentation.
Across Eurasian supply chains, sourcing supplement ingredients requires disciplined supplier qualification. Procurement and quality teams should assess Good Manufacturing Practice (GMP) status, relevant ISO certification, audit readiness, testing scope and supply continuity. The Eurasian Economic Commission’s focus on marking and product identification for dietary supplements also reinforces the need for traceable, well-documented supply partners.
Nutraceutical manufacturing teams face technical challenges when working with plant-derived ingredients. Botanical extracts can be hygroscopic, heat-sensitive, bitter, abrasive, low-density or prone to colour and odour variation. These traits can affect blending, granulation, compression, encapsulation, coating and powder filling, especially when pilot-scale performance needs to translate into commercial batches.
GMP supplement manufacturing requires control over formulation stability, batch consistency, validation and contamination risk. R&D teams need compatibility data for excipients, capsules, coatings and flavour systems. Quality teams need validated methods for identity, assay, microbial limits and impurities. For CDMOs, strong technical transfer, cleaning validation, process controls and batch documentation can turn plant-based production complexity into a commercial advantage.
Packaging plays a direct role in product quality when plant-based supplements move through longer regional distribution networks. Moisture protection, oxygen-barrier performance, tamper evidence, container-closure compatibility and labelling accuracy can affect shelf life, compliance and buyer confidence. Bottles, blister packs, sachets and stick packs should be matched to the dosage form, ingredient sensitivity and route to market.
Traceability is becoming more important as regulated distribution channels for natural health products mature. Serialisation, track-and-trace systems and accurate product data help distributors, regulators and consumers verify identity and reduce exposure to grey-market or counterfeit products. Smart healthcare packaging adds value when it supports practical goals such as packaging compliance, data integrity, aggregation and regional product movement.
For suppliers and manufacturing partners, growth in the plant-based supplements market creates stronger demand for documented capabilities. Ingredient manufacturers can support buyers through authenticated botanical supply, batch-level testing and regulatory files. Packaging providers can link barrier performance, labelling accuracy and traceability to market entry. CDMOs can support formulation development, pilot production, validation and full-cycle manufacturing for brands expanding across Eurasia.
Companies can review the Pharmtech Expo or submit a Pharmtech exhibit enquiry to discuss supplier opportunities across the plant-based supplements value chain.